The Role of TLR2 and 4-Mediated Inflammatory Pathways in Endothelial Cells Exposed to High Glucose
Tóm tắt
Từ khóa
Tài liệu tham khảo
A Ceriello, 2008, The management of post-prandial glucose, US Endocrinology, 63, 10.17925/USE.2008.04.2.63
1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6
Y Ohkubo, 1995, Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study, Diabetes Res Clin Pract, 28, 103, 10.1016/0168-8227(95)01064-K
1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401
SE Inzucchi, 2012, Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), Diabetes Care, 35, 1364, 10.2337/dc12-0413
A Gluba, 2010, The role of Toll-like receptors in renal diseases, Nat Rev Nephrol, 6, 224, 10.1038/nrneph.2010.16
K Takeda, 2005, Toll-like receptors in innate immunity, International Immunology, 17, 1, 10.1093/intimm/dxh186
M Shichiri, 2000, Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients, Diabetes Care, 23, B21
H Kawano, 1999, Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery, J Am Coll Cardiol, 34, 146, 10.1016/S0735-1097(99)00168-0
A Ceriello, 2004, Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment, Diabetes, 53, 701, 10.2337/diabetes.53.3.701
K Azuma, 2006, Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta, Arterioscler Thromb Vasc Biol, 26, 2275, 10.1161/01.ATV.0000239488.05069.03
K Esposito, 2002, Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress, Circulation, 106, 2067, 10.1161/01.CIR.0000034509.14906.AE
T Morioka, 2001, Glycemic control is a predictor of survival for diabetic patients on hemodialysis, Diabetes Care, 24, 909, 10.2337/diacare.24.5.909
CDA Stehouwer, 2004, Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease, Nephrol Dial Transplant, 19, 778, 10.1093/ndt/gfh015
A Taslipinar, 2011, The relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy, Scand J Clin Lab Invest, 71, 606, 10.3109/00365513.2011.598944
G Rudofsky, 2004, Asp299Gly and Thr399Ile Genotypes of the TLR4 Gene Are Associated With a Reduced Prevalence of Diabetic Neuropathy in Patients With Type 2 Diabetes, Diabetes Care, 27, 179, 10.2337/diacare.27.1.179
S Takata, 2013, Expression of Toll-Like Receptor 4 in Glomerular Endothelial Cells under Diabetic Conditions, Acta Histochem Cytochem, 46, 35, 10.1267/ahc.13002
S Devaraj, 2011, Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications, Metabolism, 60, 256, 10.1016/j.metabol.2010.01.005
T Kawai, 2010, The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors, Nat Immunol, 11, 373, 10.1038/ni.1863
K Zarember, 2002, Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNA in leukocytes in response to microbes, their products and cytokines, J Immunol, 168, 554, 10.4049/jimmunol.168.2.554
GE Mullins, 2004, Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1, Scand J Immunol, 60, 566, 10.1111/j.0300-9475.2004.01518.x
C Fiuza, 2003, Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells, Blood, 101, 2652, 10.1182/blood-2002-05-1300
EW Ades, 1992, HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line, J Investig Dermatol, 99, 683, 10.1111/1523-1747.ep12613748
Skrha Jr, 2012, Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus, Exp Clin Endocrinol Diabetes, 120, 277, 10.1055/s-0031-1283161
J Yang, 2010, Statins attenuate high mobility group box-1 protein induced vascular endothelial activation: a key role for TLR4/NF-kappaB signaling pathway, Mol Cell Biochem, 345, 189, 10.1007/s11010-010-0572-9
JS Park, 2006, High mobility group box 1 protein interacts with multiple Toll-like receptors, Am J Physiol Cell Physiol, 290, C917, 10.1152/ajpcell.00401.2005
L Paulis, 2012, Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent, Journal of Nanobiotechnology, 10, 25, 10.1186/1477-3155-10-25
J Li, 2010, Enhanced inflammatory responses to toll-like receptor 2/4 stimulation in type 1 diabetic coronary artery endothelial cells: the effect of insulin, Cardiovasc Diabetol, 9, 90, 10.1186/1475-2840-9-90
Panchapakesan U, Sumual S, Pollock CA, Chen X (2005) PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose. Am J Physiol Renal Physiol 289.
S Zafiriou, 2004, Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses, Kidney Int, 65, 1647, 10.1111/j.1523-1755.2004.00574.x
AE Hak, 2001, Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study, J Clin Endocrinol Metab, 86, 4398, 10.1210/jcem.86.9.7873
D Yao, 2010, Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands, Diabetes, 59, 249, 10.2337/db09-0801
JS Bae, 2011, Activated protein C inhibits high mobility group box 1 signaling in endothelial cells, Blood, 118, 3952, 10.1182/blood-2011-06-360701
K Tuttle, 2005, Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease, J Am Soc Nephrol, 16, 5, 10.1681/ASN.2005040393
SC Tang, 2011, Diabetic tubulopathy: an emerging entity, Contrib Nephrol, 170, 124, 10.1159/000325647
SC Tang, 2006, Activation of Tubular Epithelial Cells in Diabetic Nephropathy and the Role of the Peroxisome Proliferator–Activated Receptor-γ Agonist, J Am Soc Nephrol, 17, 1633, 10.1681/ASN.2005101113
HF Gu, 2012, Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy, Front Endocrinol, 3, 179
H Matsui, 1996, Expression of ICAM-1 on glomeruli is associated with progression of diabetic nephropathy in a genetically obese diabetic rat, Wistar fatty, Diabetes Research and Clinical Practice, 32, 1, 10.1016/0168-8227(96)01209-0
JJ Wang, 2008, Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy, Am J Physiol Renal Physiol, 294, F1166, 10.1152/ajprenal.00375.2007
FY Chow, 2005, Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice, J Am Soc Nephrol, 16, 1711, 10.1681/ASN.2004070612
S Okada, 2003, Intercellular Adhesion Molecule-1–Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes, Diabetes, 52, 2586, 10.2337/diabetes.52.10.2586
H Kaur, 2012, Hyperglycemia induced Toll like receptor 4 Expression and Activity in Mouse Mesangial cells: Relevance to Diabetic Nephropathy, Am J Physiol Renal Physiol, 303, F1145, 10.1152/ajprenal.00319.2012